Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Julia Perera-Bel"'
Autor:
Sara Santana-Hernández, Jesús Suarez-Olmos, Sonia Servitja, Pau Berenguer-Molins, Marcel Costa-Garcia, Laura Comerma, Anna Rea, Julia Perera-Bel, Silvia Menendez, Oriol Arpí, Begoña Bermejo, María Teresa Martínez, Juan Miguel Cejalvo, Iñaki Comino-Méndez, Javier Pascual, Emilio Alba, Miguel López-Botet, Federico Rojo, Ana Rovira, Joan Albanell, Aura Muntasell
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-15 (2024)
Abstract Background The variability in responses to neoadjuvant treatment with anti-HER2 antibodies prompts to personalized clinical management and the development of innovative treatment strategies. Tumor-infiltrating Natural Killer (TI-NK) cells ca
Externí odkaz:
https://doaj.org/article/5bc22c2f73dc42618cc14ecab70aa357
Autor:
Natalia Garcia-Giralt, Juan Du, Judith Marin-Corral, Marta Bódalo-Torruella, Fabiola Blasco-Hernando, Rosana Muñoz-Bermúdez, Miquel Clarós, Lara Nonell, Julia Perera-Bel, Marta Fernandez-González, Xavier Nogues, Luisa Sorli-Redó, Robert Güerri-Fernández
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in some cases resulting in cytokine storm syndrome and acute respiratory distress syndrome (ARDS). Several physiological parameters are altered as a result of i
Externí odkaz:
https://doaj.org/article/1d351b8ab4294df183933c9bb8dcc052
Autor:
Natalia Garcia-Giralt, Juan Du, Judith Marin-Corral, Marta Bódalo-Torruella, Fabiola Blasco-Hernando, Rosana Muñoz-Bermúdez, Miquel Clarós, Lara Nonell, Julia Perera-Bel, Marta Fernandez-González, Xavier Nogues, Luisa Sorli-Redó, Robert Güerri-Fernández
Publikováno v:
Scientific reports. 12(1)
One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in some cases resulting in cytokine storm syndrome and acute respiratory distress syndrome (ARDS). Several physiological parameters are altered as a result of infection
Autor:
Lilian Marie Boll, Júlia Perera-Bel, Alejo Rodriguez-Vida, Oriol Arpí, Ana Rovira, Núria Juanpere, Sergio Vázquez Montes de Oca, Silvia Hernández-Llodrà, Josep Lloreta, M. Mar Albà, Joaquim Bellmunt
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment and can result in complete remissions even at advanced stages of the disease. However, only a small fraction of patients respond to the treatment. To better understand w
Externí odkaz:
https://doaj.org/article/9d09f1fe0eee43aebdca7bfe8d908283
Autor:
Alexander Rombauts, Marta Bódalo Torruella, Gabriela Abelenda-Alonso, Júlia Perera-Bel, Anna Ferrer-Salvador, Ariadna Acedo-Terrades, Maria Gabarrós-Subirà, Isabel Oriol, Carlota Gudiol, Lara Nonell, Jordi Carratalà
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1348 (2023)
The clinical manifestations of SARS-CoV-2 infection vary widely, from asymptomatic infection to the development of acute respiratory distress syndrome (ARDS) and death. The host response elicited by SARS-CoV-2 plays a key role in determining the clin
Externí odkaz:
https://doaj.org/article/96bd8f8eadb94cc8b6fcfb1cea6ea4a4
Autor:
Hryhorii Chereda, Annalen Bleckmann, Kerstin Menck, Júlia Perera-Bel, Philip Stegmaier, Florian Auer, Frank Kramer, Andreas Leha, Tim Beißbarth
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-16 (2021)
Abstract Background Contemporary deep learning approaches show cutting-edge performance in a variety of complex prediction tasks. Nonetheless, the application of deep learning in healthcare remains limited since deep learning methods are often consid
Externí odkaz:
https://doaj.org/article/f1afd85784f749c9a222fea3c981750d
Autor:
Pedro Rocha, MD, Didac Ramal, MD, Enric Ripoll, MD, Laura Moliner, MD, Alex Corbera, MD, Max Hardy-Werbin, MD, PhD, Mayra Orrillo, MD, Álvaro Taus, MD, Flavio Zuccarino, MD, Joan Gibert, Júlia Perera-Bel, David Casadevall, MD, PhD, Edurne Arriola, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100115- (2021)
Introduction: Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, together with different ass
Externí odkaz:
https://doaj.org/article/aa5ac2c35017431287482d1faf250d70
Autor:
Júlia Perera-Bel, Barbara Hutter, Christoph Heining, Annalen Bleckmann, Martina Fröhlich, Stefan Fröhling, Hanno Glimm, Benedikt Brors, Tim Beißbarth
Publikováno v:
Genome Medicine, Vol 10, Iss 1, Pp 1-15 (2018)
Abstract Background A comprehensive understanding of cancer has been furthered with technological improvements and decreasing costs of next-generation sequencing (NGS). However, the complexity of interpreting genomic data is hindering the implementat
Externí odkaz:
https://doaj.org/article/9aea0e5f891c49b6a9a66b67539b4ebc